Older prostate cancer patients should think twice before undergoing treatment
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...
Cancer
15 hours ago |
not rated yet |
0
|
Two radiotherapy treatments show similar morbidity, cancer control after prostatectomy
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, ...
Cancer
17 hours ago |
not rated yet |
0
Fitness in middle age may help shield men from cancer later
(HealthDay)—Men who are physically fit in middle age have a lower risk of developing and dying from certain cancers, new research indicates.
Cancer
May 16, 2013 |
5 / 5 (1) |
0
PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced ...
Cancer
May 15, 2013 |
not rated yet |
0
Massive study closes in on cancers risk markers
Cancer research has taken a huge leap forward with scientists now able to identify more than 80 genetic markers found to increase the risk of breast, ovarian and prostate cancer. The COGS international research ...
Genetics
May 15, 2013 |
5 / 5 (2) |
0
Comorbidities should be factor in prostate biopsy choice, study finds
UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities – the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) ...
Cancer
May 15, 2013 |
not rated yet |
0
US approves radiation-based prostate cancer drug
(AP)—The U.S. Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones.
Cancer
May 15, 2013 |
not rated yet |
0
Primary care physicians vital to complete care of prostate cancer patients
Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer. However, among other side-effects, it can cause significant bone thinning in men on long-term treatment. A new study¹ by Vahakn ...
Cancer
May 14, 2013 |
not rated yet |
1
